Ondansetron and Blood Coagulation

• Status: Recruiting
• Trial end date: 2020-12-15
• Target enrollment: 0
• Participant gender: All

Summary

Ondansetron may alter whole blood coagulation. However, little is known about the dose-response relationships according to the blood concentration of ondansetron. The investigators therefore will perform the present study to measure the effect of ondansestron on the blood coagulation pathway according to the drug concentration level using a rotational thromboelastometry test.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Ondansetron

Criteria

Inclusion Criteria:

• Healthy vonlunteers

• Age: 20 to 65 years

• Body weight > 50 kg

• Volunteers who provided informed consent

Exclusion Criteria:

• Hematologic disease

• Anticoagulant medication